In January 2021, the FDA approved the following new indications/Molecules. Combination of nivolumab and cabozantinib as first-line treatment for patients...
ALK-positive
Anaplastic large-cell lymphoma (ALCL) is a rare type of non-Hodgkin lymphoma that T-cells. Pathologically, T-cells appear abnormal, large, and undeveloped. Most patients are...
